Global Human Microbiome Therapeutics Market 2020-2024

Global Human Microbiome Therapeutics Market 2020-2024

Technavio has been monitoring the human microbiome therapeutics market and it is poised to grow by USD 276.93 mn during 2020-2024 progressing at a CAGR of 15% during the forecast period. Our reports on human microbiome therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the growing prevalence of chronic diseases and robust pipeline. In addition, growing prevalence of chronic diseases is anticipated to boost the growth of the market as well.

The human microbiome therapeutics market analysis includes application segment and geographic landscapes

Technavio's human microbiome therapeutics market is segmented as below:

By Application

  • Gastrointestinal disorders
  • Immunological conditions
  • Others
By Geographic Landscapes
  • North America
  • Europe
  • APAC
  • ROW
This study identifies the side effects of existing treatment as one of the prime reasons driving the human microbiome therapeutics market growth during the next few years.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our human microbiome therapeutics market covers the following areas:
  • Human microbiome therapeutics market sizing
  • Human microbiome therapeutics market forecast
  • Human microbiome therapeutics market industry analysis
Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading human microbiome therapeutics market vendors that include Bristol-Myers Squibb Co., Dow Inc., ENTEROME SA, Ferring Pharmaceuticals AS, Johnson & Johnson, Kaleido Biosciences Inc., PureTech Health Plc, Second Genome Therapeutics, Seres Therapeutics Inc., and Takeda Pharmaceutical Co. Ltd.. Also, the human microbiome therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.


  • Executive Summary
  • Market Landscape
    • Market ecosystem
      • Table Parent market
      • Table Market characteristics
    • Value chain analysis
      • Table Value chain analysis: Pharmaceuticals
      • Research and development (R&D) and drug discovery:
      • Integration and product development:
      • Manufacturing:
      • Outbound logistics:
      • Marketing and sales:
      • Support services:
  • Market Sizing
    • Market definition
      • Table Offerings of vendors included in the market definition
    • Market segment analysis
      • Table Market segments
    • Market size 2019
    • Market outlook: Forecast for 2019 - 2024
      • Table Global - Market size and forecast 2019 - 2024 ($ million)
      • Table Global market: Year-over-year growth 2019 - 2024 (%)
  • Five Forces Analysis
    • Five forces summary
      • Table Five forces analysis 2019 & 2024
    • Bargaining power of buyers
      • Table Bargaining power of buyers
    • Bargaining power of suppliers
      • Table Bargaining power of suppliers
    • Threat of new entrants
      • Table Threat of new entrants
    • Threat of substitutes
      • Table Threat of substitutes
    • Threat of rivalry
      • Table Threat of rivalry
    • Market condition
      • Table Market condition - Five forces 2019
  • Market Segmentation by Application
    • Market segments
      • Table Application - Market share 2019-2024 (%)
    • Comparison by Application
      • Table Comparison by Application
    • Gastrointestinal disorders - Market size and forecast 2019-2024
      • Table Gastrointestinal disorders - Market size and forecast 2019-2024 ($ million)
      • Table Gastrointestinal disorders - Year-over-year growth 2019-2024 (%)
    • Immunological conditions - Market size and forecast 2019-2024
      • Table Immunological conditions - Market size and forecast 2019-2024 ($ million)
      • Table Immunological conditions - Year-over-year growth 2019-2024 (%)
    • Others - Market size and forecast 2019-2024
      • Table Others - Market size and forecast 2019-2024 ($ million)
      • Table Others - Year-over-year growth 2019-2024 (%)
    • Market opportunity by application
      • Table Market opportunity by application
  • Customer landscape
    • Table Customer landscape
  • Geographic Landscape
    • Geographic segmentation
      • Table Market share by geography 2019-2024 (%)
    • Geographic comparison
      • Table Geographic comparison
    • North America - Market size and forecast 2019- 2024
      • Table North America - Market size and forecast 2019-2024 ($ million)
      • Table North America - Year-over-year growth 2019-2024 (%)
    • Europe - Market size and forecast 2019-2024
      • Table Europe - Market size and forecast 2019-2024 ($ million)
      • Table Europe - Year-over-year growth 2019-2024 (%)
    • APAC - Market size and forecast 2019-2024
      • Table APAC - Market size and forecast 2019-2024 ($ million)
      • Table APAC - Year-over-year growth 2019-2024 (%)
    • ROW - Market size and forecast 2019-2024
      • Table ROW - Market size and forecast 2019-2024 ($ million)
      • Table ROW - Year-over-year growth 2019-2024 (%)
    • Key leading countries
      • Table Key leading countries
    • Market opportunity by geography
      • Table Market opportunity by geography ($ million)
  • Drivers, Challenges, and Trends
    • Market drivers
      • Growing prevalence of chronic diseases
      • Robust pipeline
      • Side effects of existing treatment
    • Market challenges
      • Indiscriminate use of antibiotics
      • Lack of trained professionals
      • Diverse human population
        • Table Impact of drivers and challenges
    • Market trends
      • Increase in industry-academia collaboration
      • Increasing investments
      • Increasing partnerships
  • Vendor Landscape
    • Table Vendor landscape
    • Landscape disruption
      • Table Landscape disruption
      • Table Industry risks
  • Vendor Analysis
    • Vendors covered
      • Table Vendors covered
    • Market positioning of vendors
      • Table Market positioning of vendors
    • Bristol-Myers Squibb Co.
      • Table Bristol-Myers Squibb Co. –Overview
      • Table Bristol-Myers Squibb Co. - Business segments
      • Table Bristol-Myers Squibb Co. - Key news
      • Table Bristol-Myers Squibb Co. - Key offerings
    • Dow Inc.
      • Table Dow Inc. –Overview
      • Table Dow Inc. - Business segments
      • Table Dow Inc. - Key news
      • Table Dow Inc. - Key offerings
      • Table Dow Inc. - Segment focus
    • ENTEROME SA
      • Table ENTEROME SA – Overview
      • Table ENTEROME SA - Product and service
      • Table ENTEROME SA - Key news
      • Table ENTEROME SA - Key offerings
    • Ferring Pharmaceuticals AS
      • Table Ferring Pharmaceuticals AS – Overview
      • Table Ferring Pharmaceuticals AS - Product and service
      • Table Ferring Pharmaceuticals AS - Key news
      • Table Ferring Pharmaceuticals AS - Key offerings
    • Johnson & Johnson
      • Table Johnson & Johnson – Overview
      • Table Johnson & Johnson - Business segments
      • Table Johnson & Johnson - Key news
      • Table Johnson & Johnson - Key offerings
      • Table Johnson & Johnson - Segment focus
    • Kaleido Biosciences Inc.
      • Table Kaleido Biosciences Inc. –Overview
      • Table Kaleido Biosciences Inc. - Product and service
      • Table Kaleido Biosciences Inc. - Key news
      • Table Kaleido Biosciences Inc. - Key offerings
    • PureTech Health Plc
      • Table PureTech Health Plc – Overview
      • Table PureTech Health Plc - Business segments
      • Table PureTech Health Plc - Key news
      • Table PureTech Health Plc - Key offerings
      • Table PureTech Health Plc - Segment focus
    • Second Genome Therapeutics
      • Table Second Genome Therapeutics – Overview
      • Table Second Genome Therapeutics - Product and service
      • Table Second Genome Therapeutics - Key offerings
    • Seres Therapeutics Inc.
      • Table Seres Therapeutics Inc. –Overview
      • Table Seres Therapeutics Inc. - Product and service
      • Table Seres Therapeutics Inc. - Key news
      • Table Seres Therapeutics Inc. - Key offerings
    • Takeda Pharmaceutical Co. Ltd.
      • Table Takeda Pharmaceutical Co. Ltd. –Overview
      • Table Takeda Pharmaceutical Co. Ltd. - Product and service
      • Table Takeda Pharmaceutical Co. Ltd. - Key news
      • Table Takeda Pharmaceutical Co. Ltd. - Key offerings
  • Appendix
    • Scope of the report
      • Market definition
      • Objectives
      • Notes and caveats
    • Currency conversion rates for US$
      • Table Currency conversion rates for US$
    • Research methodology
      • Table Research Methodology
      • Table Validation techniques employed for market sizing
      • Table Information sources
    • List of abbreviations
      • Table List of abbreviations

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook